Why is BioNtech SE important to traders?
Learn all about BioNTech, with information on the company’s history and share price journey, its share trading hours, and how to trade BioNTech shares with Capital.com.
Learn more about BioNtech SESpread | 0.95 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024262% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00204% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 0.1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 118.3 |
Open | 120.14 |
1-Year Change | 22.03% |
Day's Range | 117.66 - 121.21 |
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 12, 2024 | 120.00 | 0.35 | 0.29% | 119.65 | 122.88 | 118.28 |
Dec 11, 2024 | 117.83 | 0.40 | 0.34% | 117.43 | 121.57 | 116.99 |
Dec 10, 2024 | 116.95 | -3.68 | -3.05% | 120.63 | 122.63 | 116.60 |
Dec 9, 2024 | 120.75 | -1.13 | -0.93% | 121.88 | 122.97 | 117.12 |
Dec 6, 2024 | 121.39 | 3.19 | 2.70% | 118.20 | 125.15 | 116.99 |
Dec 5, 2024 | 117.80 | 3.40 | 2.97% | 114.40 | 120.27 | 112.63 |
Dec 4, 2024 | 114.40 | -1.14 | -0.99% | 115.54 | 116.83 | 113.95 |
Dec 3, 2024 | 115.00 | -1.81 | -1.55% | 116.81 | 118.43 | 115.00 |
Dec 2, 2024 | 118.39 | 0.92 | 0.78% | 117.47 | 119.30 | 116.49 |
Nov 29, 2024 | 118.15 | -2.14 | -1.78% | 120.29 | 121.09 | 117.60 |
Nov 27, 2024 | 119.95 | 1.41 | 1.19% | 118.54 | 121.45 | 116.60 |
Nov 26, 2024 | 118.14 | 0.24 | 0.20% | 117.90 | 121.45 | 116.96 |
Nov 25, 2024 | 119.95 | 7.45 | 6.62% | 112.50 | 121.00 | 112.38 |
Nov 22, 2024 | 111.88 | 4.89 | 4.57% | 106.99 | 114.02 | 106.52 |
Nov 21, 2024 | 108.13 | 5.89 | 5.76% | 102.24 | 108.65 | 100.95 |
Nov 20, 2024 | 102.04 | -4.09 | -3.85% | 106.13 | 106.97 | 100.97 |
Nov 19, 2024 | 106.39 | 3.93 | 3.84% | 102.46 | 107.87 | 101.21 |
Nov 18, 2024 | 101.20 | 1.53 | 1.54% | 99.67 | 102.37 | 98.20 |
Nov 15, 2024 | 98.63 | -2.89 | -2.85% | 101.52 | 102.74 | 94.41 |
Nov 14, 2024 | 101.52 | -9.91 | -8.89% | 111.43 | 115.85 | 101.46 |
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Founded in 2008, BioNTech is an innovative biotechnology company from Germany, specialising in the research, development and producing of active individualised immunotherapies. The company adheres to a patient-specific approach to treatment of serious diseases, such as cancer.
BioNTech shares a vision that every patient’s tumour is unique. It means that each patient’s treatment should be individualised. To implement the scientists’ ideas into practice, BioNTech has developed pioneering therapeutics for cancer and other rare and infectious diseases.
Headquartered in Mainz, Germany, the company is aimed at becoming the world’s leading biotechnology company for individialised cancer treatment. By 2020, BioNTech had more than 440 patients treated across 17 tumour types. The company has more than 1,300 employees and seven pharmaceutical partners.
In August 2018, the company partnered with the US pharmaceutical giant Pfizer Inc to develop mRNA-based vaccines for preventing influenza. In September 2019, BioNTech started working on the development of tuberculosis and HIV programmes and preclinical vaccine and immunotherapy candidates for the prevention of tuberculosis and HIV infections under an agreement with the Bill & Melinda Gates Foundation.
BioNTech stock floated on the NASDAQ stock exchange through a $150m initial public offering (IPO) in October 2019. Since then the BNTX stock quote has been traded on the US market.
In November 2020, BioNTech and Pfizer triggered the strongest wave of optimism on the stock market after they announced that their Covid-19 vaccine showed 90 per cent effectiveness during the phase-three clinical trials. The BioNTech share price soared 14 per cent the day after the announcement.
In 2019, BioNTech reported total revenues of about €109m. According to the estimates from Morgan Stanley, BioNTech and Pfizer can make around $13bn from vaccine sales, getting $6.5bn each if these estimates are correct.
Looking closely at the BioNTech stock price chart in 2020, we can see that BNTX stock has been trading in a range of $18.60-$115. Since the large sell-off in March 2020, the BioNTech SE (BNTX) stock quote grew from $28.55 on March 12, 2020, to $112.76 on November 10, 2020, which is a growth of 294 per cent.
Follow the BioNTech share price live on our interactive share price chart and build your own forecast for the famous German biotechnology company. Follow the latest BioNTech share news and spot the best levels to open profitable CFD trades at Capital.com.
Industry: | Bio Therapeutic Drugs |
An der Goldgrube 12
MAINZ
RHEINLAND-PFALZ 55131
DE
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024Learn all about BioNTech, with information on the company’s history and share price journey, its share trading hours, and how to trade BioNTech shares with Capital.com.
Learn more about BioNtech SEJoin the 660,000+ traders worldwide that chose to trade with Capital.com